10-6019818-T-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000417.3(IL2RA):​c.655+52A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.896 in 1,533,098 control chromosomes in the GnomAD database, including 619,163 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.86 ( 56906 hom., cov: 32)
Exomes 𝑓: 0.90 ( 562257 hom. )

Consequence

IL2RA
NM_000417.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.0510

Publications

11 publications found
Variant links:
Genes affected
IL2RA (HGNC:6008): (interleukin 2 receptor subunit alpha) The interleukin 2 (IL2) receptor alpha (IL2RA) and beta (IL2RB) chains, together with the common gamma chain (IL2RG), constitute the high-affinity IL2 receptor. Homodimeric alpha chains (IL2RA) result in low-affinity receptor, while homodimeric beta (IL2RB) chains produce a medium-affinity receptor. Normally an integral-membrane protein, soluble IL2RA has been isolated and determined to result from extracellular proteolyisis. Alternately-spliced IL2RA mRNAs have been isolated, but the significance of each is presently unknown. Mutations in this gene are associated with interleukin 2 receptor alpha deficiency. Patients with severe Coronavirus Disease 2019 (COVID-19), the disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have significantly elevated levels of IL2R in their plasma. Similarly, serum IL-2R levels are found to be elevated in patients with different types of carcinomas. Certain IL2RA and IL2RB gene polymorphisms have been associated with lung cancer risk. [provided by RefSeq, Jul 2020]
IL2RA Gene-Disease associations (from GenCC):
  • immunodeficiency due to CD25 deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • neonatal diabetes mellitus
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • type 1 diabetes mellitus 10
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-6019818-T-C is Benign according to our data. Variant chr10-6019818-T-C is described in ClinVar as Benign. ClinVar VariationId is 2628287.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.917 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL2RANM_000417.3 linkc.655+52A>G intron_variant Intron 5 of 7 ENST00000379959.8 NP_000408.1 P01589
IL2RANM_001308242.2 linkc.439+52A>G intron_variant Intron 4 of 6 NP_001295171.1 P01589Q5W005
IL2RANM_001308243.2 linkc.368-319A>G intron_variant Intron 3 of 5 NP_001295172.1 P01589H0Y5Z0
LOC124902368XR_007062042.1 linkn.144-1518T>C intron_variant Intron 2 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL2RAENST00000379959.8 linkc.655+52A>G intron_variant Intron 5 of 7 1 NM_000417.3 ENSP00000369293.3 P01589

Frequencies

GnomAD3 genomes
AF:
0.862
AC:
131030
AN:
152034
Hom.:
56856
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.828
Gnomad AMI
AF:
0.962
Gnomad AMR
AF:
0.738
Gnomad ASJ
AF:
0.926
Gnomad EAS
AF:
0.749
Gnomad SAS
AF:
0.856
Gnomad FIN
AF:
0.802
Gnomad MID
AF:
0.924
Gnomad NFE
AF:
0.923
Gnomad OTH
AF:
0.873
GnomAD4 exome
AF:
0.900
AC:
1243023
AN:
1380946
Hom.:
562257
Cov.:
21
AF XY:
0.900
AC XY:
622453
AN XY:
691396
show subpopulations
African (AFR)
AF:
0.828
AC:
26341
AN:
31796
American (AMR)
AF:
0.658
AC:
29368
AN:
44618
Ashkenazi Jewish (ASJ)
AF:
0.929
AC:
23822
AN:
25646
East Asian (EAS)
AF:
0.772
AC:
30347
AN:
39302
South Asian (SAS)
AF:
0.861
AC:
72917
AN:
84664
European-Finnish (FIN)
AF:
0.816
AC:
43541
AN:
53380
Middle Eastern (MID)
AF:
0.903
AC:
5066
AN:
5608
European-Non Finnish (NFE)
AF:
0.925
AC:
960287
AN:
1038232
Other (OTH)
AF:
0.890
AC:
51334
AN:
57700
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
6889
13779
20668
27558
34447
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19506
39012
58518
78024
97530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.862
AC:
131128
AN:
152152
Hom.:
56906
Cov.:
32
AF XY:
0.854
AC XY:
63517
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.828
AC:
34361
AN:
41486
American (AMR)
AF:
0.738
AC:
11279
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.926
AC:
3215
AN:
3472
East Asian (EAS)
AF:
0.748
AC:
3875
AN:
5178
South Asian (SAS)
AF:
0.856
AC:
4123
AN:
4814
European-Finnish (FIN)
AF:
0.802
AC:
8498
AN:
10590
Middle Eastern (MID)
AF:
0.935
AC:
273
AN:
292
European-Non Finnish (NFE)
AF:
0.923
AC:
62795
AN:
68012
Other (OTH)
AF:
0.869
AC:
1834
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
894
1789
2683
3578
4472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.891
Hom.:
8256
Bravo
AF:
0.851
Asia WGS
AF:
0.784
AC:
2728
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 89% of patients studied by a panel of primary immunodeficiencies. Number of patients: 85. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.6
DANN
Benign
0.35
PhyloP100
0.051
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10752175; hg19: chr10-6061781; API